$ATEC

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.

Original reporting
Published Oct 29, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alphatec: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$ATECBearishMed
01

Why it matters

The key tradable inputs are the Q3 revenue miss versus consensus and the stated full-year revenue expectation of $862M, which can drive estimate revisions and near-term sentiment.

02

Market read

A company-specific earnings print with explicit guidance is likely to move the stock and reset expectations for the rest of the year.

03

What to watch

The article does not break out segment performance, backlog, or margin drivers; traders may need the earnings call details to judge whether the miss is demand-related or timing-related.

Relevance 8/10Novelty 8/10Timing: reported Thursday after the quarter closed, with immediate post-release positioning

Background

Alphatec is a medical equipment and supplies company; the article frames its third-quarter results and compares revenue to Street forecasts.

Company-level read

Ticker impact

$ATECBearishHigh confidence
Context

Alphatec reported Q3 revenue of $221.2M and a loss of 3 cents per share, missing Street forecasts and reiterating full-year revenue guidance of $862M.

Expected impact

Likely pressure as the market digests the revenue miss versus consensus and weighs whether the $862M full-year outlook is credible.

Evidence & confidence

The article provides the company’s Q3 results versus analyst expectations and a specific full-year revenue expectation, both direct inputs to near-term estimates and sentiment.

Market effects

Weak quarter at a medical equipment supplier can reinforce cautious sentiment toward medtech demand and execution risk, though it is single-company specific.

Limited, as the disclosure is company-specific with no broader regional macro signal.

Low, since the news is not tied to global supply shocks or cross-border policy.

Counterpoint

The guidance provides a concrete full-year revenue target, which could stabilize expectations if investors believe the miss is temporary and margins may improve later.

Key entities

  • Alphatec Holdings Inc.

    Reported Q3 loss and revenue, missed analyst forecasts, and provided full-year revenue guidance.

  • Zacks Investment Research

    Provided the Street forecast figure cited in the article.

Related articles

$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

$ATECMed

ATEC Reports Third Quarter Financial Results

Alphatec Holdings, Inc. (ATEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ATEC Reports Third Quarter Financial Results Total revenue of $221 million, up 13% year-over-year Surgical revenue of $202 million increased 14% Case volumes grew 20% and net new surgeon users increased 25% CARLSBAD, Calif., October 29, 2026 – Alphatec Holdings, Inc.